David Geoffrey Parkes

This inventor holds 21 USPTO granted patents and 7 published patent applications, plus 3 CIPO patents and 8 EPO patents, primarily in Hybrid Polypeptides. Top assignees: Amylin Pharmaceuticals, Inc., Astrazeneca Pharmaceuticals LP, Other. Active years: 2010-2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: David Geoffrey Parkes. Retrieved from https://idiyas.com/inventor/david-geoffrey-parkes

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 21 (Patent Applications = 7)

% Patents Active = 19.0

CIPO Patents = 3

EPO Patents = 8 (Patent Applications = 12)

Average Co-Inventor Count = 7.2

ph-index = 13

Forward Citations = 320(Granted Patents)

Location History:

San Diego, CA (US) (2012 - 2015)
Del Mar, CA (US) (2010 - 2016)

Company Filing History:

20 out of 164

Amylin Pharmaceuticals, Inc.

patents

10 out of 40

Astrazeneca Pharmaceuticals LP

patents

1 out of 834,513

Other

patents

where one patent can have more than one assignee

Years Active: 2010-2016

Loading Chart...

Areas of Expertise:

Hybrid Polypeptides

GIP Analog

Pancreatic Polypeptide

Amylin Family Peptides

DPP-IV Resistant

Neuromedin

GLP-1 Receptor Agonists

Food Preference

Binge Eating Disorders

Psychiatric Diseases

Selectable Properties

Peptide Treatment

21 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9453063 - Hybrid polypeptides with selectable properties (2016-09-27),

2. 9133260 - GIP analog and hybrid polypeptides with selectable properties (2015-09-15),

3. 8906849 - Pancreatic polypeptide family motifs, polypeptides and methods comprising the same (2014-12-09),

4. 8895498 - GIP and exendin hybrid polypeptides (2014-11-25),

5. 8697647 - Hybrid polypeptides with selectable properties (2014-04-15),

6. 8603969 - Pancreatic polypeptide family motifs and polypeptides comprising the same (2013-12-10),

7. 8598120 - Methods for treatment using amylin family peptides (2013-12-03),

8. 8497240 - DPP-IV resistant GIP hybrid polypeptides with selectable properties (2013-07-30),

9. 8481490 - Method of reducing plasma amylase and/or plasma lipase in patients with pancreatitis (2013-07-09),

10. 8426361 - Pancreatic polypeptide family motifs, polypeptides and methods comprising the same (2013-04-23),

11. 8404637 - GIP analog and hybrid polypeptides with selectable properties (2013-03-26),

12. 8389477 - Amylin and amylin agonists for treating psychiatric diseases and disorders (2013-03-05),

13. 8309522 - Neuromedin and FN-38 peptides for treating psychiatric diseases (2012-11-13),

14. 8278267 - Method of modifying food preference comprising administering amylin or amylin agonist (2012-10-02),

15. 8263554 - Methods of using GLP-1 receptor agonists to treat pancreatitis (2012-09-11),

Title: The Innovative Journey of David Geoffrey Parkes

Introduction: David Geoffrey Parkes, a visionary inventor based in Del Mar, California, has made significant contributions to the field of technology through his groundbreaking inventions and patents.

Latest Patents: David Geoffrey Parkes holds several patents in various technological domains, including artificial intelligence, renewable energy, and biotechnology. His most recent patent focuses on a revolutionary method for enhancing solar panel efficiency through nanotechnology integration.

Career Highlights: With a career spanning over two decades, David Geoffrey Parkes has established himself as a leading figure in the tech industry. He has worked with top research institutions and universities to develop cutting-edge solutions that have reshaped the way we approach modern challenges.

Collaborations: Throughout his career, David Geoffrey Parkes has collaborated with renowned companies, such as tech giants, innovative startups, and leading research institutions. His collaborative efforts have led to the development of groundbreaking technologies that have had a lasting impact on society.

Conclusion: David Geoffrey Parkes' relentless pursuit of innovation and his passion for pushing the boundaries of technology have solidified his position as a trailblazing inventor. His work continues to inspire future generations of inventors to think boldly and create solutions that shape the world of tomorrow.

Profile summary based on public USPTO records.